COZMA MD LTD
Company number 12821556 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
COZMA MD LTD - Analysis Report
Company Number: 12821556
Analysis Date: 2025-07-20 15:17 UTC
Financial Health Assessment for COZMA MD LTD
1. Financial Health Score: B+
Explanation:
COZMA MD LTD shows strong financial stability with solid working capital, increasing net assets, and healthy liquidity, especially for a company operating in the construction sector. The company’s balance sheet demonstrates a robust buffer of current assets over current liabilities and growing fixed assets, indicating investment in long-term operational capacity. However, the relatively small share capital and limited employee base, combined with some increase in creditor obligations, suggest room for improvement in capital structure and operational scale to achieve an “A” rating.
2. Key Vital Signs
| Metric | 2024 Value | Interpretation |
|---|---|---|
| Turnover | £630,377 (2023)* | Moderate revenue for a small construction firm; growth not available for 2024 but good base. |
| Current Assets | £217,060 | Healthy level of short-term assets to cover liabilities. |
| Cash & Cash Equivalents | £196,927 | Very strong liquidity position, a “healthy cash flow” sign allowing operational flexibility. |
| Debtors | £20,133 | Moderate trade receivables; manageable given turnover scale. |
| Current Liabilities | £39,854 | Increased from prior year but still well covered by current assets. |
| Net Current Assets | £177,206 | Positive working capital “pulse,” signaling the company can meet short-term obligations comfortably. |
| Fixed Assets (net) | £98,545 | Significant increase, reflecting investment in motor vehicles; suggests growth and capacity build. |
| Total Net Assets | £265,497 | Increasing shareholder equity shows retained earnings and business value growth. |
| Share Capital | £1 | Minimal capital base; typical for private limited companies but could limit external confidence. |
| Employee Count | 1 | Very lean operation, possibly owner-managed; low payroll risk but also limited manpower capacity. |
*Turnover for 2024 not disclosed; 2023 turnover used as latest available figure.
3. Diagnosis: Financial Condition Analysis
COZMA MD LTD presents the financial "vital signs" of a small but growing construction business. The company’s liquidity is notably strong, with cash making up the vast majority of current assets, ensuring no immediate "symptoms of distress" from cash flow shortages. The rise in fixed assets, particularly motor vehicles, indicates reinvestment in operational capacity, a positive "growth pulse" signaling readiness to handle more projects.
The working capital position is robust, with net current assets nearly five times the current liabilities, suggesting excellent short-term financial health and ability to meet creditor demands promptly. Net assets and shareholder funds have more than doubled since inception, reflecting value creation and profit retention over the years.
However, the tiny share capital and very small workforce indicate a company that is still very much in a nascent or boutique phase, which could limit scalability and access to larger contracts or financing. The increase in creditors (current liabilities) also warrants monitoring to ensure it doesn’t signal emerging payment delays or supplier financing stress.
Overall, the company exhibits no alarming financial symptoms such as negative working capital, accumulated losses, or poor liquidity. The financial "heartbeat" is steady, and the company appears solvent and adequately capitalized for its current scale.
4. Recommendations: Steps to Improve Financial Wellness
Increase Share Capital or Equity Injection:
Raising the nominal share capital or injecting additional equity could strengthen the capital base, improving credibility with banks and suppliers and supporting future growth or loan applications.Diversify Workforce and Skills:
Consider hiring to broaden operational capacity and reduce owner dependency risks. This would support project scaling and reduce workload risks.Monitor Creditors and Payment Terms:
Keep a close eye on creditor balances and payment cycles to avoid any creeping liquidity strain. Negotiate favorable payment terms or early payment discounts to improve cash flow.Focus on Turnover Growth and Profit Margins:
While turnover is moderate, strategic marketing and client diversification could enhance revenue streams. Improving profit margins through cost control and operational efficiencies would enhance retained earnings and financial resilience.Plan for Contingencies:
Maintain a cash buffer aligned with at least 3-6 months of operating expenses to guard against economic downturns or project delays, a "healthy cash flow reserve."Consider Formal Financial Reporting and Audit:
As the company grows, adopting full audited accounts could increase transparency and stakeholder confidence, facilitating external financing or partnerships.
Medical Analogy Summary
The company’s financial health resembles a patient with a strong heart rate and robust blood flow—in this case, liquidity and net assets—signaling vitality and growth potential. However, the small capital "immune system" and limited workforce suggest vulnerability to external shocks or operational stress if growth accelerates rapidly. Proactive "preventive medicine" through capital strengthening and workforce expansion will enhance resilience and promote sustainable healthy growth.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.